Higher therapeutic plasma oxypurinol concentrations must be required for gouty patients with chronic kidney disease.
| Autor: | Panomvana D, Sripradit S, Angthararak S |
|---|---|
| Zdroj: | JRC: Journal of Clinical Rheumatology; 2008 Feb, Vol. 14 Issue 1, p6-11, 6p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|